{"id":464317,"date":"2021-03-24T10:03:16","date_gmt":"2021-03-24T14:03:16","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=464317"},"modified":"2021-03-24T10:03:16","modified_gmt":"2021-03-24T14:03:16","slug":"vygr-deadline-bronstein-gewirtz-grossman-llc-notifies-voyager-therapeutics-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-march-24-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-deadline-bronstein-gewirtz-grossman-llc-notifies-voyager-therapeutics-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-march-24-2021\/","title":{"rendered":"VYGR Deadline: Bronstein, Gewirtz & Grossman, LLC Notifies Voyager Therapeutics, Inc.\u00a0Shareholders of Class Action and Lead Plaintiff Deadline: March 24, 2021"},"content":{"rendered":"
\n

NEW YORK, March 24, 2021 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against\u00a0Voyager Therapeutics, Inc.\u00a0<\/strong>(“Voyager” or “the Company”) (NASDAQ: VYGR) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Voyager securities between June 1, 2017\u00a0and\u00a0November 9, 2020, both dates inclusive (the “Class Period”).\u00a0Such investors are encouraged to join this case by visiting the firm\u2019s site: www.bgandg.com\/vygr<\/a>.\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0<\/p>\n

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.<\/p>\n

The complaint alleges that throughout the Class Period, Defendants made materially false and\/or misleading statements, and failed to disclose to investors that: (1) Voyager\u2019s VY-HTT01 IND submission to the FDA lacked key information regarding certain chemistry, manufacturing and controls (“CMC”) matters, including,\u00a0inter alia<\/em>, drug-device compatibility and drug substance and product characterization; (2) the Company’s IND submission for VY-HTT01 was therefore deficient; (3)\u00a0the Company had thus materially overstated the likelihood of FDA approval for VY-HTT01 based on the IND submission; and (4) as a result, the Company’s public statements were materially false and misleading at all relevant times.<\/p>\n

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm\u2019s site: www.bgandg.com\/vygr<\/a> or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Voyager you have until March 24, 2021 to request that the Court appoint you as lead plaintiff.\u00a0 Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.<\/p>\n

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.\u00a0 Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.\u00a0 In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm\u2019s expertise includes general corporate and commercial litigation, as well as securities arbitration.\u00a0 \u00a0Attorney advertising. Prior results do not guarantee similar outcomes.<\/p>\n

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com<\/a><\/p>\n

\n
\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

NEW YORK, March 24, 2021 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against\u00a0Voyager Therapeutics, Inc.\u00a0(“Voyager” or “the Company”) (NASDAQ: VYGR) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Voyager securities between June 1, 2017\u00a0and\u00a0November 9, 2020, both dates inclusive (the “Class Period”).\u00a0Such investors are encouraged to join this case by visiting the firm\u2019s site: www.bgandg.com\/vygr.\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934. The complaint alleges that throughout the Class Period, Defendants made materially false and\/or misleading statements, and … <\/p>\n

Continue reading “VYGR Deadline: Bronstein, Gewirtz & Grossman, LLC Notifies Voyager Therapeutics, Inc.\u00a0Shareholders of Class Action and Lead Plaintiff Deadline: March 24, 2021”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-464317","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nVYGR Deadline: Bronstein, Gewirtz & Grossman, LLC Notifies Voyager Therapeutics, Inc.\u00a0Shareholders of Class Action and Lead Plaintiff Deadline: March 24, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-deadline-bronstein-gewirtz-grossman-llc-notifies-voyager-therapeutics-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-march-24-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"VYGR Deadline: Bronstein, Gewirtz & Grossman, LLC Notifies Voyager Therapeutics, Inc.\u00a0Shareholders of Class Action and Lead Plaintiff Deadline: March 24, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, March 24, 2021 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against\u00a0Voyager Therapeutics, Inc.\u00a0(“Voyager” or “the Company”) (NASDAQ: VYGR) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Voyager securities between June 1, 2017\u00a0and\u00a0November 9, 2020, both dates inclusive (the “Class Period”).\u00a0Such investors are encouraged to join this case by visiting the firm\u2019s site: www.bgandg.com\/vygr.\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934. The complaint alleges that throughout the Class Period, Defendants made materially false and\/or misleading statements, and … Continue reading "VYGR Deadline: Bronstein, Gewirtz & Grossman, LLC Notifies Voyager Therapeutics, Inc.\u00a0Shareholders of Class Action and Lead Plaintiff Deadline: March 24, 2021"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-deadline-bronstein-gewirtz-grossman-llc-notifies-voyager-therapeutics-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-march-24-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-24T14:03:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MzMzNSM0MDczMTc1IzIwMTc2OTA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vygr-deadline-bronstein-gewirtz-grossman-llc-notifies-voyager-therapeutics-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-march-24-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vygr-deadline-bronstein-gewirtz-grossman-llc-notifies-voyager-therapeutics-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-march-24-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"VYGR Deadline: Bronstein, Gewirtz & Grossman, LLC Notifies Voyager Therapeutics, Inc.\u00a0Shareholders of Class Action and Lead Plaintiff Deadline: March 24, 2021\",\"datePublished\":\"2021-03-24T14:03:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vygr-deadline-bronstein-gewirtz-grossman-llc-notifies-voyager-therapeutics-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-march-24-2021\\\/\"},\"wordCount\":385,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vygr-deadline-bronstein-gewirtz-grossman-llc-notifies-voyager-therapeutics-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-march-24-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE5MzMzNSM0MDczMTc1IzIwMTc2OTA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vygr-deadline-bronstein-gewirtz-grossman-llc-notifies-voyager-therapeutics-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-march-24-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vygr-deadline-bronstein-gewirtz-grossman-llc-notifies-voyager-therapeutics-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-march-24-2021\\\/\",\"name\":\"VYGR Deadline: Bronstein, Gewirtz & Grossman, LLC Notifies Voyager Therapeutics, Inc.\u00a0Shareholders of Class Action and Lead Plaintiff Deadline: March 24, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vygr-deadline-bronstein-gewirtz-grossman-llc-notifies-voyager-therapeutics-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-march-24-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vygr-deadline-bronstein-gewirtz-grossman-llc-notifies-voyager-therapeutics-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-march-24-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE5MzMzNSM0MDczMTc1IzIwMTc2OTA=\",\"datePublished\":\"2021-03-24T14:03:16+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vygr-deadline-bronstein-gewirtz-grossman-llc-notifies-voyager-therapeutics-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-march-24-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vygr-deadline-bronstein-gewirtz-grossman-llc-notifies-voyager-therapeutics-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-march-24-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vygr-deadline-bronstein-gewirtz-grossman-llc-notifies-voyager-therapeutics-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-march-24-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE5MzMzNSM0MDczMTc1IzIwMTc2OTA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE5MzMzNSM0MDczMTc1IzIwMTc2OTA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vygr-deadline-bronstein-gewirtz-grossman-llc-notifies-voyager-therapeutics-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-march-24-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"VYGR Deadline: Bronstein, Gewirtz & Grossman, LLC Notifies Voyager Therapeutics, Inc.\u00a0Shareholders of Class Action and Lead Plaintiff Deadline: March 24, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"VYGR Deadline: Bronstein, Gewirtz & Grossman, LLC Notifies Voyager Therapeutics, Inc.\u00a0Shareholders of Class Action and Lead Plaintiff Deadline: March 24, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-deadline-bronstein-gewirtz-grossman-llc-notifies-voyager-therapeutics-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-march-24-2021\/","og_locale":"en_US","og_type":"article","og_title":"VYGR Deadline: Bronstein, Gewirtz & Grossman, LLC Notifies Voyager Therapeutics, Inc.\u00a0Shareholders of Class Action and Lead Plaintiff Deadline: March 24, 2021 - Market Newsdesk","og_description":"NEW YORK, March 24, 2021 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against\u00a0Voyager Therapeutics, Inc.\u00a0(“Voyager” or “the Company”) (NASDAQ: VYGR) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Voyager securities between June 1, 2017\u00a0and\u00a0November 9, 2020, both dates inclusive (the “Class Period”).\u00a0Such investors are encouraged to join this case by visiting the firm\u2019s site: www.bgandg.com\/vygr.\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934. The complaint alleges that throughout the Class Period, Defendants made materially false and\/or misleading statements, and … Continue reading \"VYGR Deadline: Bronstein, Gewirtz & Grossman, LLC Notifies Voyager Therapeutics, Inc.\u00a0Shareholders of Class Action and Lead Plaintiff Deadline: March 24, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-deadline-bronstein-gewirtz-grossman-llc-notifies-voyager-therapeutics-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-march-24-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-24T14:03:16+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MzMzNSM0MDczMTc1IzIwMTc2OTA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-deadline-bronstein-gewirtz-grossman-llc-notifies-voyager-therapeutics-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-march-24-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-deadline-bronstein-gewirtz-grossman-llc-notifies-voyager-therapeutics-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-march-24-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"VYGR Deadline: Bronstein, Gewirtz & Grossman, LLC Notifies Voyager Therapeutics, Inc.\u00a0Shareholders of Class Action and Lead Plaintiff Deadline: March 24, 2021","datePublished":"2021-03-24T14:03:16+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-deadline-bronstein-gewirtz-grossman-llc-notifies-voyager-therapeutics-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-march-24-2021\/"},"wordCount":385,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-deadline-bronstein-gewirtz-grossman-llc-notifies-voyager-therapeutics-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-march-24-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MzMzNSM0MDczMTc1IzIwMTc2OTA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-deadline-bronstein-gewirtz-grossman-llc-notifies-voyager-therapeutics-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-march-24-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-deadline-bronstein-gewirtz-grossman-llc-notifies-voyager-therapeutics-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-march-24-2021\/","name":"VYGR Deadline: Bronstein, Gewirtz & Grossman, LLC Notifies Voyager Therapeutics, Inc.\u00a0Shareholders of Class Action and Lead Plaintiff Deadline: March 24, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-deadline-bronstein-gewirtz-grossman-llc-notifies-voyager-therapeutics-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-march-24-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-deadline-bronstein-gewirtz-grossman-llc-notifies-voyager-therapeutics-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-march-24-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MzMzNSM0MDczMTc1IzIwMTc2OTA=","datePublished":"2021-03-24T14:03:16+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-deadline-bronstein-gewirtz-grossman-llc-notifies-voyager-therapeutics-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-march-24-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/vygr-deadline-bronstein-gewirtz-grossman-llc-notifies-voyager-therapeutics-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-march-24-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-deadline-bronstein-gewirtz-grossman-llc-notifies-voyager-therapeutics-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-march-24-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MzMzNSM0MDczMTc1IzIwMTc2OTA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MzMzNSM0MDczMTc1IzIwMTc2OTA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-deadline-bronstein-gewirtz-grossman-llc-notifies-voyager-therapeutics-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-march-24-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"VYGR Deadline: Bronstein, Gewirtz & Grossman, LLC Notifies Voyager Therapeutics, Inc.\u00a0Shareholders of Class Action and Lead Plaintiff Deadline: March 24, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/464317","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=464317"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/464317\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=464317"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=464317"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=464317"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}